XML 64 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments - Fair Value Measurements, Additional Information (Details)
9 Months Ended
Sep. 30, 2018
USD ($)
Dec. 31, 2017
USD ($)
Carrying Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt, fair value $ 5,390,000,000 $ 5,440,000,000
Estimated Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt, fair value 5,500,000,000 $ 5,580,000,000
Mac Dermid    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term contingent consideration (up to) $ 100,000,000  
Price performance metrics period 7 years  
Contingent Consideration, Common Stock Performance Target    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Percentage change in rate affecting component measurement (as a percent) 1.00%  
Measurement component change affected by change in discount rate $ 900,000  
Contingent Consideration, Common Stock Performance Target | Mac Dermid    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Business acquisition expected future value payments $ 40,000,000.0  
Contingent Consideration, Adjusted EBITDA Performance Metric    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Percentage change in rate affecting component measurement (as a percent) 1.00%  
EBITDA metric, measurement component change affected by change in discount rate $ 1,300,000  
Contingent Consideration, Adjusted EBITDA Performance Metric | Minimum    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
EBITDA probability range (as a percent) 80.00%  
Contingent Consideration, Adjusted EBITDA Performance Metric | Maximum    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
EBITDA probability range (as a percent) 100.00%  
Contingent Consideration, Adjusted EBITDA Performance Metric | Mac Dermid    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Business acquisition expected future value payments $ 60,000,000.0  
Measurement Input, Discount Rate | Contingent Consideration, Common Stock Performance Target | Mac Dermid    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
EBITDA related earnout include a discount rate (as a percent) 0.0284  
Measurement Input, Discount Rate | Contingent Consideration, Adjusted EBITDA Performance Metric | Mac Dermid    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
EBITDA related earnout include a discount rate (as a percent) 0.1000